Obesity is a huge problem in the developed world, and it’s getting bigger.According to the World Health Organization (WHO), people with a body mass index (BMI) 27 April 2018
A huge reduction in opioid prescriptions is the most striking feature of the latest report from the IQVIA Institute for Human Data Science on medicine usage and 19 April 2018
When pharma bosses talk about innovation, they are referring both to the research and development (R&D) that goes into discovering and bringing new medicines to 11 April 2018
At first glance, the global pharmaceutical industry, often regarded as slow-moving, conservative and resistant to change, appears infertile ground for an innova 3 April 2018
Continued growth in Bayer’s Pharmaceuticals unit ensured that the German life sciences group’s 2017 financial results at least had an air of respectability abou 13 March 2018
In recent years, a small nonprofit research organization in Boston, Massachusetts, has quietly acquired a significant amount of influence over pricing negotiati 19 February 2018
For years, China has been viewed with a mixture of excitement, optimism and suspicion by western pharmaceutical firms, with nervous investors wary of the relati 22 January 2018
It’s impossible to imagine how many lives antibiotics have saved since penicillin was first synthesized by Alexander Fleming in 1928 - certainly tens, if not hu 14 December 2017
It is the third-most common disorder in the world.In the USA.close to 38 million people suffer from it.Globally.the number is a whopping 1 billion.We are talkin 11 December 2017
A familiar argument voiced in pharma is that the price of new drugs has to be kept high to pay for tomorrow’s medicines.and those pursuing new innovations can p 24 November 2017
Alnylam Pharmaceuticals, which with some justification bills itself as the leading RNAi company, isn’t shy of mentioning the Nobel-prize winning provenance of i 17 November 2017
Thomas Busby and Oded Ben-Joseph, from investor bank Outcome Capital, look at some of the hurdles to accessing venture capital, and how companies can overcome t 10 November 2017
Michael Ellenbogen, who was diagnosed with younger-onset Alzheimer’s disease in 2008, was invited to give a talk to staff at a major pharma company last week. H 31 October 2017
On November 20, the question of which country will host the European Medicines Agency post-Brexit will finally be settled, at the European Council’s General Aff 25 October 2017
In this week's feature, Michael Jewell, the healthcare partner at Cavendish Corporate Finance, looks at a new initiative by Pfizer, the world’s largest pharmace 17 October 2017
Dr Nicola Davies explores pharmaceutical development in mental health, with a focus on factors that influence the road to pharma-psych innovation. 3 October 2017
Yitzhak Peterburg, Teva’s (NYSE: TEVA) last but one CEO, recently described the pharmaceutical industry as one of the last “traditional” industries, saying it w 27 September 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.